Product Information
QUETIAPINE ER 200 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.2201 per EA under NDC 16729009512. Its NADAC has been published 466 times since Jun 21, 2017.
FDA first approved this application on Nov 1, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the QUETIAPINE FUMARATE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729009512
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA090681FDA Approved
11/1/2016
TE Code
AB
On Market Since
1/1/2019
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE ER 200 MG TABLET has been published 466 times since Jun 21, 2017, and over the history we have for it it has declined 98.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2201 per EA |
|---|---|
| All-time high | $12.0123 (Jul 12, 2017) |
| All-time low | $0.1768 (Jul 17, 2024) |
| 52-week high | $0.2346 |
| 52-week low | $0.2178 |
| Median price | $0.4084 |
| Average price | $0.5905 |
| Largest weekly change | -79.1% (Jul 19, 2017) |
| Weeks tracked | 466 |
| Tracking since | Jun 21, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
-6.0%
1Y
-1.7%
3Y
-13.9%
5Y
-53.9%
All
-98.2%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the QUETIAPINE FUMARATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUETIAPINE ER 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 200 MG TABLET, manufactured by Accord Healthcare Inc., is $0.2201 per EA (NDC 16729009512), effective May 20, 2026.
How has the price of QUETIAPINE ER 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUETIAPINE ER 200 MG TABLET has declined 98.2%. It has been tracked across 466 weekly CMS publications since Jun 21, 2017.
What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 200 MG TABLET?
Since Jun 21, 2017, the NADAC for QUETIAPINE ER 200 MG TABLET has ranged from a low of $0.1768 (Jul 17, 2024) to a high of $12.0123 (Jul 12, 2017), with a median of $0.4084 per EA.
Are there cheaper alternatives to QUETIAPINE ER 200 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of QUETIAPINE ER 200 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QUETIAPINE ER 200 MG TABLET?
QUETIAPINE ER 200 MG TABLET (NDC 16729009512) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.